The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These groundbreaking therapies represent a https://heathxnnb132890.magicianwiki.com/1851819/glp_3_receptor_agonists_retatrutide_trizepatide